<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2022 (10) TMI 797 - CESTAT AHMEDABAD</title>
    <link>https://www.taxtmi.com/caselaws?id=429239</link>
    <description>Duty under Notification No. 43/2001-CE (NT) could be discharged through available Cenvat credit because no statutory bar prevented such utilisation, and the cited precedent accepted that mode of payment. Cenvat credit was also admissible on inputs and packing materials used for trial manufacture, testing and quality control of exhibit batches, since those activities formed part of the manufacturing process and credit could not be denied merely because the batches were later destroyed within the factory. Medicaments cleared under non-returnable challans for testing and sampling were not liable to excise duty because they had not attained marketability and samples consumed or destroyed in testing do not attract levy.</description>
    <language>en-us</language>
    <pubDate>Tue, 18 Oct 2022 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 21 Oct 2022 07:24:41 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=693855" rel="self" type="application/rss+xml"/>
    <item>
      <title>2022 (10) TMI 797 - CESTAT AHMEDABAD</title>
      <link>https://www.taxtmi.com/caselaws?id=429239</link>
      <description>Duty under Notification No. 43/2001-CE (NT) could be discharged through available Cenvat credit because no statutory bar prevented such utilisation, and the cited precedent accepted that mode of payment. Cenvat credit was also admissible on inputs and packing materials used for trial manufacture, testing and quality control of exhibit batches, since those activities formed part of the manufacturing process and credit could not be denied merely because the batches were later destroyed within the factory. Medicaments cleared under non-returnable challans for testing and sampling were not liable to excise duty because they had not attained marketability and samples consumed or destroyed in testing do not attract levy.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Tue, 18 Oct 2022 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=429239</guid>
    </item>
  </channel>
</rss>